JCI Insight – LSD1 promotes prostate cancer cell reprogramming by repressing TP53 signaling independently of its demethylase function

ResearchIn-Press PreviewOncology Open Access | 10.1172/jci.insight.167440 Zhi Duan,2 Diana Flores,1 Chao Zhang,1 Archana Sehrawat,3 Ya-Mei Hu,4 Olivia A. Swaim,1 Eva Rodansky,1 William K. Storck,1 Joshua A. Kuleape,1 Karan Bedi,5 Rahul Mannan,6 Xiao-Ming Wang,6 Aaron M. Udager,6…

Read the full article here

Source: insight.jci.org

Categories: Hem/Oncs, Latest Headlines

Tweets with this article

EllisLab_

RT @anbu4genes: Very happy to share our new work out in @JCI_insight- https://t.co/MRUsZ2y7MI. This work was made possible by help and supp…

JCI Insight – Sociodemographic factors and research experience impact MD-PhD program acceptance

Abstract The 2014 NIH Physician-Scientist Workforce Working Group predicted a future shortage of physician-scientists. Subsequent studies have highlighted disparities in MD-PhD admissions based on race,…

john doe 5 February 23, 2024

JCI Insight – Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression

Animal experiments. C57BL/6J (WT; catalog 000664) mice were purchased from Jackson Laboratory. FXR whole-body KO mice (FXR-KO) and FXR-specific deletion mice (FXRfl/fl) were gifted from…

Medical Xpress January 24, 2024

JCI Insight – TMTC4 is a hair cell–specific human deafness gene

Research ArticleOtology Open Access | 10.1172/jci.insight.172665 Byung Yoon Choi,3 Yasmin Eltawil,4 Noura Ismail Mohamad,4 Yesai Park,4 Ian R. Matthews,4 Jin Hee Han,3,5 Bong Jik Kim,5…

Neuroscience News January 8, 2024

JCI Insight – Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine

ResearchIn-Press PreviewCOVID-19Immunology Open Access | 10.1172/jci.insight.172510 Thomas Cleven,1 Hailey Bussan,1 Boyd L. Yount Jr.,2 Ryuta Uraki,3 Kiyoko Iwatsuki-Horimoto,3 Michiko Koga,4 Shinya Yamamoto,4 Hiroshi Yotsuyanagi,4 Hongtae…

Medical Xpress November 7, 2023

JCI Insight – MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF

ResearchIn-Press PreviewOncology Open Access | 10.1172/jci.insight.173688 Takahiro Utsumi,1 Yuki Shimizu,1 Ai Takemoto,1 Tomoko Oh-hara,1 Ken Uchibori,2 Sophia Subat-Motoshi,3 Hironori Ninomiya,3 Kengo Takeuchi,4 Makoto Nishio,2 Yasunari…

Robert C. Doebele, MD, PhD November 4, 2023

JCI Insight – Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies to self-antigens

ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/jci.insight.172449 Jonathan Preall,1 Johannes Yeh,1 Darryl J. Pappin,1 Paolo Cifani,1 Yixin Zhao,2 Sophia Shen,3 Philip Moresco,1 Brian He,1 Hardik Patel,1…

Anirban Maitra September 26, 2023

JCI Insight – HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease

ResearchIn-Press PreviewDermatology Open Access | 10.1172/jci.insight.166076 Ping-Min Chen,2 Matthew D. Vesely,1 Rahanna N. Khan,1 Jacob Fiedler,3 James Garritano,4 Fahrisa M. Islam,1 Jennifer M. McNiff,1 and…

Dr. John Cush August 19, 2023

JCI Insight – HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease

Dr. John Cush August 14, 2023

JCI Insight – HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease

Dr. John Cush August 8, 2023

JCI Insight – Positive and negative regulation of the Fcγ receptor-stimulatory activity of RNA-containing immune complexes by RNase

ResearchIn-Press Preview Open Access | 10.1172/jci.insight.167799 Koichiro Ohmura,1 Shuhei Higuchi,2 Wataru Nakai,2 Masako Kohyama,2 Tsuneyo Mimori,4 Akio Morinobu,1 and Hisashi Arase5 1Department of Rheumatology and…

Medical Xpress July 18, 2023

Related Articles